CARE Ratings (CARERATING) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
18 Nov, 2025Executive summary
Revenue from operations grew 19% year-over-year to ₹78.92 Cr on a consolidated basis in Q1 FY25.
Consolidated PAT increased 16% year-over-year to ₹21.38 Cr, with PAT margin stable at 24%.
Standalone revenue rose 16% year-over-year to ₹65.34 Cr, with EBITDA up 10% and PAT up 11%.
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, were approved by the Board on August 7, 2024.
Board approved changes in the composition of its committees, effective immediately.
Financial highlights
Consolidated EBITDA grew 22% year-over-year to ₹21.82 Cr, with margin at 28%.
Standalone EBITDA margin was 34%, PAT margin 31%, and EPS increased 10% to ₹8.04.
Consolidated EPS rose 16% year-over-year to ₹6.94.
Total consolidated expenses increased 17% year-over-year to ₹60.36 Cr.
Consolidated profit before tax was ₹3,042.69 lakhs, up from ₹2,641.39 lakhs year-over-year.
Segment performance
Ratings business contributed 90% of consolidated revenue, growing 19% year-over-year.
Ratings and related services contributed ₹7,065.20 lakhs in segment revenue, while 'Others' contributed ₹844.10 lakhs for the quarter.
Non-ratings business contributed ₹8.27 Cr, up 31% year-over-year.
Segment results before finance costs and tax: Ratings and related services at ₹2,262.32 lakhs, 'Others' at -₹360.49 lakhs.
Latest events from CARE Ratings
- Strong revenue and margin growth, led by ratings, with regulatory and product developments.CARERATING
Q3 25/2611 Feb 2026 - Strong revenue and profit growth, global expansion, and interim dividend declared.CARERATING
Q2 24/2518 Nov 2025 - Record revenue, profit growth, and international expansion marked a strong FY25.CARERATING
Q4 24/2518 Nov 2025 - Strong profit growth, interim dividend, and strategic subsidiary stake sale in Q2 FY26.CARERATING
Q2 25/2614 Nov 2025 - Double-digit growth in income and profits, with stable governance and clean audit review.CARERATING
Q1 25/268 Aug 2025 - Q3FY25 revenue and profit surged YoY, led by ratings and non-ratings growth.CARERATING
Q3 24/255 Jun 2025